These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32620)

  • 21. Development of the noradrenergic innervation of neocortex.
    Levitt P; Moore RY
    Brain Res; 1979 Feb; 162(2):243-59. PubMed ID: 761089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of the dopaminergic innervation of the rat cerebral cortex. A light microscopic immunocytochemical study using anti-tyrosine hydroxylase antibodies.
    Verney C; Berger B; Adrien J; Vigny A; Gay M
    Brain Res; 1982 Sep; 281(1):41-52. PubMed ID: 6182953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of central neurotransmitter systems.
    Johnston MV; Coyle JT
    Ciba Found Symp; 1981; 86():251-70. PubMed ID: 6121688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective ablation of neurons by methylazoxymethanol during pre- and postnatal brain development.
    Chen S; Hillman DE
    Exp Neurol; 1986 Oct; 94(1):103-19. PubMed ID: 3758276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deformed dendrites and reduced spine numbers on ectopic neurones in the hippocampus of rats exposed to methylazoxymethanol-acetate. A Golgi-Cox study.
    Singh SC
    Acta Neuropathol; 1980; 49(3):193-8. PubMed ID: 7368897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective loss of noradrenergic phenotypic characters in neuroblasts of the rat embryo.
    Jonakait GM; Wolf J; Cochard P; Goldstein M; Black IB
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4683-6. PubMed ID: 41248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the regenerative capacity of central dopaminergic, noradrenergic and cholinergic neurones using iris implants as targets.
    Emson PC; Björklund A; Stenevi U
    Brain Res; 1977 Oct; 135(1):87-105. PubMed ID: 21020
    [No Abstract]   [Full Text] [Related]  

  • 28. Depletion of cholinergic habenulo-interpeduncular neurons by selectively timed methylazoxymethanol acetate (MAM) treatment during pregnancy.
    Virgili M; Barnabei O; Contestabile A
    Brain Res; 1988 Sep; 460(2):361-5. PubMed ID: 3224267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal methylazoxymethanol acetate uncouples coincidence of orientation of cerebellar folia and parallel fibers.
    Hillman DE; Chen S; Ackman J
    Neuroscience; 1988 Jan; 24(1):99-110. PubMed ID: 3368061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep-waking cycle in microencephalic rats induced by prenatal methylazoxymethanol application.
    Kiyono S; Seo M; Shibagaki M
    Electroencephalogr Clin Neurophysiol; 1980 Jan; 48(1):73-9. PubMed ID: 6153325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catecholaminergic innervation of luteinizing hormone-releasing hormone and glutamic acid decarboxylase immunopositive neurons in the rat medial preoptic area. An electron-microscopic double immunostaining and degeneration study.
    Leranth C; MacLusky NJ; Shanabrough M; Naftolin F
    Neuroendocrinology; 1988 Dec; 48(6):591-602. PubMed ID: 2471942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of methylazoxymethanol treatment on the GABAergic synaptosomes in the P2 fraction from developing mouse cerebellum.
    Bacon E; Girard C; de Barry J; Gombos G
    Biochem Soc Trans; 1991 Nov; 19(4):431S. PubMed ID: 1665442
    [No Abstract]   [Full Text] [Related]  

  • 33. Developmental changes of GABAergic synapses formed between primary cultured cortical neurons.
    Kato-Negishi M; Muramoto K; Kawahara M; Kuroda Y; Ichikawa M
    Brain Res Dev Brain Res; 2004 Sep; 152(2):99-108. PubMed ID: 15351497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of mouse cerebellar circuits following methylazoxymethanol treatment during development: immunohistochemistry of GABAergic elements and electron microscopic study.
    de Barry J; Gombos G; Klupp T; Hamori J
    J Comp Neurol; 1987 Jul; 261(2):253-65. PubMed ID: 3305601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal exposure to methylazoxymethanol (MAM) acetate: effects on ultrasonic vocalization and locomotor activity in rat offspring.
    Cagiano R; De Salvia M; Renna G; Racagni G; Cuomo V
    Arch Toxicol Suppl; 1987; 11():148-51. PubMed ID: 3477156
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurotrophic effects of cAMP generating systems on central noradrenergic neurons.
    Sklair-Tavron L; Segal M
    Brain Res; 1993 Jun; 614(1-2):257-69. PubMed ID: 8102314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor induction in intact and regenerating liver of adult rats by a single treatment with methylazoxymethanol acetate.
    Zedeck MS; Sternberg SS
    Chem Biol Interact; 1977 Jun; 17(3):291-6. PubMed ID: 880698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ectopic glial cells in rat cerebella following neonatal administration of methylazoxymethanol acetate.
    Hillman DE; Chen S; Chen V
    Brain Res; 1988 May; 447(2):353-9. PubMed ID: 3390704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of methylazoxymethanol-induced lesions in the postnatal mouse cerebellum.
    Jones MZ; Gardner E
    J Neuropathol Exp Neurol; 1976 Jul; 35(4):413-44. PubMed ID: 932788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sleep-wakefulness cycle and spindle bursts during paradoxical sleep in microencephalic rats induced by prenatal administration of methylazoxymethanol (MAM) acetate.
    Sano K; Matsumoto J
    Tokushima J Exp Med; 1982 Jun; 29(1-2):1-9. PubMed ID: 7147236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.